Acufocus Inc 32 Discoverysuite 200irvine Ca 92618 Pma Numberp210005 Supplement Numbers004 Date Received11 04 2022 Decision Date12 02 2022 Product Code Poe Advisory Committee Ophthalmic Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Acufocus Inc 32 Discoverysuite 200irvine Ca 92618 Pma Numberp210005 Supplement Numbers004 Date Received11 04 2022 Decision Date12 02 2022 Product Code Poe Advisory Committee Ophthalmic Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

FDA Filings

Device
Company
DeviceDate
AcuFocus, Inc.32 Discoverysuite 200irvine, CA 92618 PMA NumberP210005 Supplement NumberS004 Date Received11/04/2022 Decision Date12/02/2022 Product Code POE  Advisory Committee Ophthalmic Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No
IC-8 Apthera Intraocular Lens (IOL)2022-12-02

Related Finance Registrations

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.